Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions

Journal of Histochemistry and Cytochemistry

Volumn 53, Issue 4, 2005, Pages 509-516

  Guimarães, Márcia C M ^a   Gonçalves, Maria Alice G ^a   Soares, Christiane P ^b   Bettini, Jussara S R ^a   Duarte, Roberta A ^b   Soares, Edson G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Bcl 2; Carcinogenesis; Human papillomavirus; p16INK4a; Squamous intraepithelial lesions

Indexed keywords

PEROXIDASE; PROTEIN BCL 2; PROTEIN E6; PROTEIN E7; PROTEIN P16INK4A; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; BIOSYNTHESIS; CLASSIFICATION; METABOLISM; PAPILLOMA VIRUS; PATHOGENICITY; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES; MARTES PENNANTI;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 16244395459     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.4A6312.2005     Document Type: Article

References (50)

1. Alani RM, Munger K (1998) Human papillomaviruses and associated malignancies. J Clin Oncol 16:330-337
2. Brychtova S, Brychta T, Kotrsova L, Pilka R, Tichy M, Ticha V, Kolar Z (2000) Expression of Bcl-2 in dysplastic and neoplastic cervical lesions in relation to cell proliferation and HPV infection. Neoplasma 47:143-147
3. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, et al. (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 8:27-32
4. Canavan TP, Doshi NR (2000) Cervical cancer. Am Fam Physician 61:1369-1376
5. Chan SY, Delius H, Halpern AL, Bernard HU (1995) Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 69:3074-3083
6. Chang KC, Su IJ, Tsai ST, Shieh DB, Jin YT (2002) Pathological features of betel quid-related oral epithelial lesions in Taiwan with special emphasis on the tumor progression and human papillomavirus association. Oncology 63:362-369
7. Ciavattini A, Lucarini G, Castaldini C, Goreti G, Romanini C, Biagini G, Garzetti GG (1999) bcl-2 protein expression in cervical intraepithelial neoplasias: no evidence of a prognostic significance in mild and moderate lesions. Anticancer Res 19:5463-5467
8. Coleman N, Stanley MA (1994) Analysis of HLA-DR expression on keratinocytes in cervical neoplasia. Int J Cancer 56:314-319
9. Crawford RAF, Caldwell C, Hes RK, Lowe D, Shepherd JH, Chard T (1998) Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer. Br J Cancer 78:210-214
10. Dimitrakakis C, Kymionis G, Diakomanolis E, Papaspyrou I, Rodolakis A, Arzimanoglou I, Leandros E, et al. (2000) The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol Oncol 77:129-136
11. Esteller M, Gonzalez S, Risques RA, Marcuello E, Mangues R, Germa JR, Herman JG, et al. (2001) K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. J Clin Oncol 19:299-304
12. Frank TS, Svoboda-Newman SM, Hsi ED (1996) Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR. Diag Mol Pathol 5:220-224
13. Fregonesi PA, Teresa DB, Duarte RA, Neto CB, de Oliveira MR, Soares CP (2003) p16 (INK4A) immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem 51:1291-1297
14. Gillet G, Brun G (1996) Viral inhibition of apoptosis. Trends Microbiol 4:312-317
15. Green DR, Bissonnette RP, Cotter TG (1994) Apoptosis and cancer. In De Vita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. Philadelphia, Lippincott, 37-52
16. Hayashi N, Sugimoto Y, Tsuchiya E, Ogawa M, Nakamura Y (1994) Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4I (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem Biophys Res Commun 202:1426-1430
17. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, et al. (2000) Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92:464-474
18. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336
19. IARC (1995) Human papillomaviruses. In Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, International Agency for Research on Cancer, 64
20. Jain D, Srinivasan R, Patel F, Gupta SK (2003) Evaluation of p53 and bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy. Gynecol Oncol 88:22-28
21. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, et al. (2001) Ki-67, cyclin E, and p16INK4 are complementary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 25:884-891
22. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, et al. (2001) Overexpression of p16 INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276-284
23. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, ter Harmsel B, et al. (1998) A novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153:1731-1739
24. Kohlberger P, Edwards L, Hacker N (2003) Microinvasive squamous cell carcinoma of the cervix: immunohistochemically detected prognostic factors in a case with poor clinical outcome. Gynecol Oncol 90:443-445
25. Kouzarides T (1995) Functions of pRb and p53: what's the connection? Trends Cell Biol 5:448-450
26. Kurvinen K, Syrjänen K, Syrjänen S (1996) p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions. J Clin Oncol 14:2120-2130
27. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, et al. (2003) p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 56:56-63
28. Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, et al. (2002) Cyclin D1 amplification and p16 (MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 112:472-481
29. Nasiell K, Roger V, Nasiell M (1986) Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 67:665-669
30. Pisani P, Bray F, Parkin DM (2002) Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97:72-81
31. Plas DR, Thompson CB (2002) Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab 13:75-78
32. Rihakova P, Brychtova S, Kotrsova L, Pilka R, Kolar Z (2001) DNA ploidy correlates with grade, proliferation and clinical outcome but not with presence of human oncogenic HPVs or expression of Bcl-2 in preneoplastic and neoplastic lesions of the uterine cervix. Neoplasma 48:274-277
33. Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nunez G, Clarke MF (1994) c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 91:5878-5882
34. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, et al. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491
35. Sakaguchi M, Fujii Y, Hirabayashi H, Yoon HE, Komoto Y, Oue T, Kusafuka T, et al. (1996) Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int J Cancer 65:442-445
36. Salvesen H, Das S, Akslen L (2000) Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Clinical Cancer Research January 6:153-159
37. Sanguinetti CJ, Dias Neto E, Simpson AJ (1994) Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17:914-921
38. Sano T, Masuda N, Oyama T, Nakajima T (2002) Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 52:375-383
39. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998) Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153:1741-1748
40. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM (1990) The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 71:173-181
41. Straume O, Sviland L, Akslen L (2000) Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Clin Cancer Res 6:1845-1853
42. Sturm I, Petrowsky H, VoIz R, Lorenz M, Radetzki S, Hillebrand T, Wolff G, et al. (2001) Analysis of p53/BAX/p16 ink4a/CDKN2 in esophageal squamous cell carcinoma: high BAX and p16 ink4a/CDKN2 identifies patients with good prognosis. J Clin Oncol 19:2272-2281
43. Takita J, Hayashi Y, Nakajima T, Adachi J, Tanaka T, Yamaguchi N, Ogawa Y, et al. (1998) The p16 (CDKN2A) gene is involved in the growth of neuroblastoma cells and its expression is associated with prognosis of neuroblastoma patients. Oncogene. 17:3137-3143
44. Ter Harmsel B, Smedts F, Kuijpers J, Jeunink M, Trimbos B, Ramaekers F (1996) bcl-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma. J Pathol 179:26-30
45. Ting Y, Manos M (1990) Detection and typing of genital human papillomaviruses. Polymerase Chain Reaction Protocols: A guide to methods and applications. San Diego, Academic Press, 356-367
46. Uehara T, Kuwashima Y, Izumo T, Kishi K, Shiromizu K, Matsuzawa M (1995) Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome. Eur J Gynaecol Oncol 16:453-460
47. Van de Putte G, Holm R, Lie K, Trope CG, Kristensen GB (2003) Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol 89:140-147
48. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, et al. (1999) Human papillomavirus is a necessary cause of invasive cancer worldwide. J Pathol 189:12-19
49. Werness BA, Levine AJ, Howley PM (1990) Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science 248:76-79
50. zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698